Literature DB >> 23999714

Protective effects of interleukin-4 on tissue destruction and morphological changes of bovine nasal chondrocytes in vitro.

Maryam Yadegari1, Mahmoud Orazizadeh, Mahmoud Hashemitabar, Ali Khodadadi.   

Abstract

BACKGROUND: Previous studies have shown that some cytokines have protective effects on cartilage in joint diseases. In the current study, effects of IL-4 against morphological changes and tissue degradation induced by IL-1α on bovine nasal cartilage (BNC) explants were investigated.
METHODS: Fresh BNC samples were prepared from a slaughterhouse under sterile conditions. BNC explants culture was treated with both IL-lα (10 ng/ml) and IL-4 (50 ng/ml) at the same time for 28 days. The morphological characteristics of explants were assessed by using histology techniques and invert microscopy. Matrix metalloproteinase-1 (MMP-1) production was assessed within different days by using Western blotting.
RESULTS: IL-lα induced prominent cartilage morphology degradation. The pro and active form of MMP-1 band substantially increased at day 21 of culture. In the presence of both IL-lα and IL-4, chondrocytes preserved their ordinary normal phenotype with intact extracellular matrix. In addition, a significant reduction in pro-MMP-1and inhibition of active MMP-1 was seen.
CONCLUSION: In conclusion, IL-4 could be regarded as a potential candidate in cartilage protecting against the degradation changes of IL-lα. It seems that the preservation effect of IL-4 is associated with significant reduction of MMP-1.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23999714      PMCID: PMC3882921          DOI: 10.6091/ibj.1219.2013

Source DB:  PubMed          Journal:  Iran Biomed J        ISSN: 1028-852X


  24 in total

1.  Chondrocyte phenotypes on different extracellular matrix monolayers.

Authors:  K R Brodkin; A J García; M E Levenston
Journal:  Biomaterials       Date:  2004-12       Impact factor: 12.479

2.  Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown.

Authors:  W D Shingleton; A J Ellis; A D Rowan; T E Cawston
Journal:  J Cell Biochem       Date:  2000-09-14       Impact factor: 4.429

3.  Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.

Authors:  F A van de Loo; O J Arntz; F H van Enckevort; P L van Lent; W B van den Berg
Journal:  Arthritis Rheum       Date:  1998-04

4.  Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.

Authors:  C S Cleaver; A D Rowan; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

5.  Suppression of matrix metalloproteinase-3 synthesis by interleukin-4 in human articular chondrocytes.

Authors:  O Nemoto; H Yamada; T Kikuchi; M Shinmei; K Obata; H Sato; M Seiki; M Shimmei
Journal:  J Rheumatol       Date:  1997-09       Impact factor: 4.666

6.  Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.

Authors:  J M Milner; S F Elliott; T E Cawston
Journal:  Arthritis Rheum       Date:  2001-09

7.  Interleukin-4 blocks the release of collagen fragments from bovine nasal cartilage treated with cytokines.

Authors:  T E Cawston; A J Ellis; H Bigg; V Curry; E Lean; D Ward
Journal:  Biochim Biophys Acta       Date:  1996-12-12

8.  Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures.

Authors:  L D Kozaci; D J Buttle; A P Hollander
Journal:  Arthritis Rheum       Date:  1997-01

9.  Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts.

Authors:  R C Borghaei; P L Rawlings; E Mochan
Journal:  Arthritis Rheum       Date:  1998-08

10.  Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis.

Authors:  M J Green; A K S Gough; J Devlin; J Smith; P Astin; D Taylor; P Emery
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.